Hello and Welcome to Patientsville.com, Your Source for all ALENDRONATE information. We are dedicated to provide You with ALENDRONATE safety information. Learn about ALENDRONATE serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ALENDRONATE Safety Reports
Total ALENDRONATE reports: 30.ALENDRONATE FDA safety alerts: 2007 .
Reported deaths: 3 Reported hospitalizations: 8.
Take ALENDRONATE Side Effects Survey or Share Your ALENDRONATE Story. Read More Here.
Pharmacist from UNITED STATES reported ALENDRONATE problem on Jan 24, 2007. Male patient, 73 years of age, weighting 176.4 lb, was diagnosed with osteoporosis and was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: pharyngeal oedema. ALENDRONATE dosage: 70 MG ONE TIME DOSE. During the same period patient was treated with ALBUTEROL, AMITRIPTYLINE, AMMONIUM LACTATE, CAPSAICIN, CLOPIDOGREL, DESIPRAMINE, FELODIPINE, FLUTICASONE. Patient recovered.
ALENDRONATE problem was reported by a Pharmacist from UNITED STATES on Jan 25, 2007. Male patient, 83 years of age, weighting 156.0 lb, was diagnosed with osteoporosis and was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: abscess, osteomyelitis, pain, pathological fracture, purulence, soft tissue inflammation, swelling. ALENDRONATE dosage: 75 MG WEEKLY PO. Patient was hospitalized and became disabled. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ALENDRONATE problem on Jan 31, 2007. Male patient, 57 years of age, weighting 187.6 lb, was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: oesophagitis. ALENDRONATE dosage: unknown. Patient recovered.
ALENDRONATE problem was reported by a Health Professional from AUSTRALIA on Feb 08, 2007. Male patient, 42 years of age, was diagnosed with bone disorder and was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: osteonecrosis. ALENDRONATE dosage: unknown. During the same period patient was treated with CALCIUM CARBONATE. Patient recovered.
Health Professional from AUSTRALIA reported ALENDRONATE problem on Feb 08, 2007. Female patient, 76 years of age, was diagnosed with bone disorder, essential hypertension and was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: gingivitis, malocclusion, osteonecrosis, periodontitis. ALENDRONATE dosage: unknown. During the same period patient was treated with VERAPAMIL HYDROCHLORIDE. Patient recovered.
ALENDRONATE problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2007. Female patient, 84 years of age, weighting 141.5 lb, was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: diarrhoea. ALENDRONATE dosage: unknown. Patient recovered.
Physician from SINGAPORE reported ALENDRONATE problem on Mar 15, 2007. Female patient, 55 years of age, was diagnosed with osteoporosis, eczema and was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: femur fracture, pain in extremity. ALENDRONATE dosage: unknown. Patient was hospitalized. Patient recovered.
ALENDRONATE problem was reported by a Pharmacist from UNITED STATES on Apr 02, 2007. Male patient, weighting 110.2 lb, was diagnosed with osteoporosis and was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: diarrhoea, gastrointestinal haemorrhage, renal failure acute. ALENDRONATE dosage: 70MG WEEKLY PO. During the same period patient was treated with ASPIRIN, EPOETIN ALFA, FERROUS SULPHATE. Patient was hospitalized. Patient died on 05/31/2006.
Pharmacist from UNITED STATES reported ALENDRONATE problem on Apr 10, 2007. Female patient, 67 years of age, weighting 178.6 lb, was diagnosed with osteoporosis and was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: joint swelling. ALENDRONATE dosage: 70MG WEEKLY PO. Patient recovered.
ALENDRONATE problem was reported by a Physician from KOREA, REPUBLIC OF on Apr 06, 2007. Female patient, 69 years of age, weighting 130.1 lb, was diagnosed with osteoporosis and was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: appendicitis. ALENDRONATE dosage: unknown. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported ALENDRONATE problem on May 22, 2007. Male patient, 70 years of age, was diagnosed with osteoporosis and was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: erythema multiforme, sunburn. ALENDRONATE dosage: 70MG QWEEK PO. Patient recovered.
ALENDRONATE problem was reported by a Physician from UNITED STATES on July 11, 2006. Male patient, 77 years of age, weighting 196.4 lb, was diagnosed with osteopenia and was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, dyspnoea. ALENDRONATE dosage: 70MG ONCE A WEEK PO. Patient recovered.
Pharmacist from UNITED STATES reported ALENDRONATE problem on July 24, 2006. Male patient, 84 years of age, weighting 136.7 lb, was diagnosed with osteoporosis and was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: dysphagia, oesophageal food impaction, oesophageal rupture, oesophageal stenosis, oesophagitis. ALENDRONATE dosage: 70MG WEEKLY PO. During the same period patient was treated with ALBUTEROL SPIROS, ASPIRIN, CALCIUM CARBONATE, LANOXIN, FLUNISOLIDE, FORMOTEROL, HYDROCHLOROTHIAZIDE, IPRATROPIUM BROMIDE. Patient was hospitalized. Patient recovered.
ALENDRONATE problem was reported by a Consumer or non-health professional from BRAZIL on July 25, 2006. Female patient, 66 years of age, weighting 147.7 lb, was diagnosed with mineral supplementation, thrombosis prophylaxis and was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: allergic cough, asthma, dyspnoea. ALENDRONATE dosage: unknown. During the same period patient was treated with OSCAL D, SYNTHROID, PLAVIX. Patient recovered.
Physician from GERMANY reported ALENDRONATE problem on Feb 07, 2006. Female patient, 83 years of age, was diagnosed with osteoporosis and was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: anorexia, asthma, atrial fibrillation, bronchitis, cardiac failure, cardiovascular insufficiency, chest pain, concussion, confusional state. ALENDRONATE dosage: unknown. During the same period patient was treated with LISINOPRIL, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient died on 01/22/2006.
ALENDRONATE problem was reported by a Consumer or non-health professional from BRAZIL on July 25, 2006. Female patient, 66 years of age, weighting 147.7 lb, was diagnosed with mineral supplementation, thrombosis prophylaxis and was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: allergic cough, asthma. ALENDRONATE dosage: unknown. During the same period patient was treated with OSCAL D, SYNTHROID, PLAVIX. Patient recovered.
Pharmacist from GERMANY reported ALENDRONATE problem on Aug 01, 2006. Female patient, 67 years of age, weighting 136.7 lb, was diagnosed with osteoporosis and was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: chorioretinitis, rheumatoid factor increased, urticaria. ALENDRONATE dosage: unknown. During the same period patient was treated with LEVOTHYROXINE AND POTASSIUM IODIDE, CALCIUM CARBONATE AND CHOLECALCIFEROL. Patient was hospitalized. Patient recovered.
ALENDRONATE problem was reported by a Physician from PHILIPPINES on July 31, 2006. Female patient, 59 years of age, was diagnosed with osteoporosis, hypertension, hypercholesterolaemia, routine health maintenance and was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: dry skin, pruritus. ALENDRONATE dosage: unknown. During the same period patient was treated with IRBESARTAN, ROSUVASTATIN CALCIUM, FOSAMAX. Patient recovered.
Physician from JAPAN reported ALENDRONATE problem on Oct 04, 2006. Female patient, 48 years of age, was diagnosed with metastases to bone and was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: osteonecrosis. ALENDRONATE dosage: unknown. Patient recovered.
ALENDRONATE problem was reported by a Physician from JAPAN on Oct 04, 2006. Female patient, 48 years of age, was diagnosed with metastases to bone and was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: osteonecrosis. ALENDRONATE dosage: unknown. Patient recovered.
Consumer or non-health professional from JAPAN reported ALENDRONATE problem on Oct 04, 2006. Female patient, 48 years of age, was diagnosed with metastases to bone and was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: activities of daily living impaired, osteonecrosis. ALENDRONATE dosage: unknown. Patient recovered.
ALENDRONATE problem was reported by a Physician from GERMANY on Jan 16, 2006. Female patient, 64 years of age, was diagnosed with osteoporosis and was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: hyperplasia, nasal disorder, nasal polyps, nasal septum deviation, osteomyelitis, osteonecrosis, rhinitis. ALENDRONATE dosage: unknown. During the same period patient was treated with MAGNESIUM OROTATE, AMYLASE AND BROMELAINS AND CHYMOTRYPSIN AND LIPASE AND PANCREATIN AND, CALCIUM CITRATE AND CHOLECALCIFEROL, METOPROLOL SUCCINATE, PYRIDOXINE HYDROCHLORIDE AND THIAMINE HYDROCHLORIDE, ETILEFRINE, ATORVASTATIN CALCIUM, MEDICINALPRODUCT NOT SPECIFIED BY SENDER. Patient was hospitalized and became disabled. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ALENDRONATE problem on Dec 06, 2006. Female patient, 65 years of age, weighting 215.2 lb, was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: pruritus. ALENDRONATE dosage: unknown. Patient recovered.
ALENDRONATE problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 06, 2006. Male patient, 70 years of age, weighting 182.1 lb, was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: osteonecrosis. ALENDRONATE dosage: unknown. Patient recovered.
Health Professional from SWEDEN reported ALENDRONATE problem on July 02, 2007. Female patient, 59 years of age, was diagnosed with polymyalgia rheumatica and was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: tooth disorder. ALENDRONATE dosage: unknown. During the same period patient was treated with LEVOTHYROXINE, CALCIUM CARBONATE AND CHOLECALCIFEROL, PREDNISOLONE. Patient recovered.
ALENDRONATE problem was reported by a Consumer or non-health professional from JAPAN on Oct 25, 2006. Female patient, 48 years of age, was diagnosed with metastases to bone and was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: osteonecrosis. ALENDRONATE dosage: 5 MG DAILY; PO. During the same period patient was treated with BISPHONAL. Patient recovered.
Pharmacist from UNITED STATES reported ALENDRONATE problem on July 23, 2007. Male patient, 73 years of age, was diagnosed with osteoporosis and was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: anaemia, gastrointestinal haemorrhage, oesophagitis. ALENDRONATE dosage: 70MG WEEKLY PO. During the same period patient was treated with APAP, RAMIPRIL, VERAPAMIL, COLACE, SIMVASTATIN, PHENYTOIN, FERROUS SULPHATE, ASCORBIC ACID. Patient recovered.
ALENDRONATE problem was reported by a Pharmacist from UNITED STATES on July 25, 2007. Female patient, 51 years of age, weighting 148.2 lb, was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: nausea, vomiting. ALENDRONATE dosage: unknown. Patient recovered.
Physician from CANADA reported ALENDRONATE problem on Aug 13, 2007. Female patient, 87 years of age, was diagnosed with osteoporosis and was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: breast cancer, lung neoplasm malignant, metastatic squamous cell carcinoma. ALENDRONATE dosage: 70 MG, WEEKLY (1/W). During the same period patient was treated with ACTONEL, TERIPARATIDE, CALCIUM W, VITAMIN D, VITAMIN D. Patient died on 06/09/2007.
ALENDRONATE problem was reported by a Pharmacist from UNITED STATES on Sept 18, 2007. Male patient, 76 years of age, was diagnosed with osteoporosis and was treated with ALENDRONATE. After drug was administered, patient experienced the following problems/side effects: pruritus, urticaria. ALENDRONATE dosage: 70MG QWEEK PO. Patient recovered.